Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICH trial of regional citrate versus systemic heparin anticoagulation for CRRT in critically ill patients with acute kidney injury
2014-004854-33Phase 4Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Nov 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute kidney failure (AKF) comparing Regional citrate anticoagulation with Systemic heparin anticoagulation (2 arms). Primary endpoints: Filter life span and 90-day all-cause mortality. Started Nov 2015; status: completed.
02
Drugs
trisodium citrateheparin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2014-004854-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004854-33.